AXIAL THERAPEUTICS, INC.

Profile

Company Names

AXIAL THERAPEUTICS, INC.
AXIAL BIOTHERAPEUTICS, INC.

Addresses

400 TRADECENTER DRIVE, SUITE 6990, WOBURN, MA 01801

400 TRADECENTER DRIVE, SUITE 6990, WOBURN, MA 01801

9 FOURTH AVENUE, WALTHAM, MA 02451

745 BOYLSTON ST., 6TH FLOOR SUITE 602, BOSTON, MA 02116

745 BOYLSTON ST., SUITE 602, BOSTON, MA 02116

800 BOYLSTON ST., SUITE 1555, BOSTON, MA 02199

Phone Numbers

(781) 701-8484
(781) 701-8467
(617) 874-5260
(617) 351-2590

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$109,787,815.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2025-01-28 
$19,379,799.00 
$22,000,000.00 
$2,620,201.00 
Equity 
6
2023-10-18 
$11,054,030.00 
$24,000,000.00 
$12,945,970.00 
Debt 
5
2021-05-11 
$27,352,547.00 
$37,806,866.00 
$10,454,319.00 
Equity, Debt 
4
2020-05-07 
$7,825,000.00 
$8,000,000.00 
$175,000.00 
Debt 
3
2019-06-18 
$5,000,000.00 
$10,000,000.00 
$5,000,000.00 
Equity 
2
2018-11-09 
$20,026,439.00 
$28,000,000.00 
$7,973,561.00 
Equity 
1
2016-11-22 
$19,150,000.00 
$19,150,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
P. 
ALDRICH 
DIRECTOR
SCOTT 
C. 
BRUN 
DIRECTOR
A. 
STEWART 
CAMPBELL 
EXECUTIVE OFFICER, DIRECTOR
MICHELE 
 
CUCULLU 
DIRECTOR
ERIC 
 
DE LA FORTELLE 
DIRECTOR
DAVID 
H. 
DONABEDIAN 
EXECUTIVE OFFICER, DIRECTOR
NORA 
 
FREY 
DIRECTOR
SARKIS 
K. 
MAZMANIAN 
DIRECTOR
SARAH 
 
MEIBUSCH 
DIRECTOR
MARK 
 
OHORI 
DIRECTOR
RONALD 
C. 
RENAUD JR. 
DIRECTOR
REBECCA 
 
SENTER 
EXECUTIVE OFFICER
HENRY 
C. 
WOLF 
DIRECTOR
JEFFREY 
E. 
YOUNG 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-01-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-10-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-05-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-07 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JMP SECURITIES LLC